{"id":"https://openalex.org/W7224766818","doi":"https://doi.org/10.1016/j.adro.2026.102205","title":"Tumor-Informed Circulating Tumor DNA Monitoring for Predicting Outcomes in Patients With Head and Neck Squamous Cell Carcinoma","display_name":"Tumor-Informed Circulating Tumor DNA Monitoring for Predicting Outcomes in Patients With Head and Neck Squamous Cell Carcinoma","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7224766818","doi":"https://doi.org/10.1016/j.adro.2026.102205"},"language":"en","primary_location":{"id":"doi:10.1016/j.adro.2026.102205","doi":"https://doi.org/10.1016/j.adro.2026.102205","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.adro.2026.102205","pdf_url":"https://www.advancesradonc.org/article/S2452-1094(26)00211-3/pdf","source":{"id":"https://openalex.org/S2765008485","display_name":"Advances in Radiation Oncology","issn_l":"2452-1094","issn":["2452-1094"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Radiation Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.advancesradonc.org/article/S2452-1094(26)00211-3/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5120535955","display_name":"Sydney F. Denney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134113660","display_name":"University of Nevada, Reno","ror":"https://ror.org/01keh0577","country_code":"US","type":"education","lineage":["https://openalex.org/I134113660"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sydney F. Denney","raw_affiliation_strings":["University of Nevada, Reno School of Medicine, Reno, Nevada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nevada, Reno School of Medicine, Reno, Nevada","institution_ids":["https://openalex.org/I134113660"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137208731","display_name":"George Laliotis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124610","display_name":"Natera (United States)","ror":"https://ror.org/02anzyy56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124610"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Laliotis","raw_affiliation_strings":["Department of Oncology, Natera, Inc., Austin, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Natera, Inc., Austin, Texas","institution_ids":["https://openalex.org/I4210124610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075389749","display_name":"Charuta C. Palsuledesai","orcid":"https://orcid.org/0000-0002-3850-260X","observed_orcids":["https://orcid.org/0000-0002-3850-260X"]},"institutions":[{"id":"https://openalex.org/I4210124610","display_name":"Natera (United States)","ror":"https://ror.org/02anzyy56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124610"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charuta C. Palsuledesai","raw_affiliation_strings":["Department of Oncology, Natera, Inc., Austin, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Natera, Inc., Austin, Texas","institution_ids":["https://openalex.org/I4210124610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042228191","display_name":"Giby V. George","orcid":"https://orcid.org/0009-0007-9529-4564","observed_orcids":["https://orcid.org/0009-0007-9529-4564"]},"institutions":[{"id":"https://openalex.org/I4210124610","display_name":"Natera (United States)","ror":"https://ror.org/02anzyy56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124610"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giby V. George","raw_affiliation_strings":["Department of Oncology, Natera, Inc., Austin, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Natera, Inc., Austin, Texas","institution_ids":["https://openalex.org/I4210124610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044949957","display_name":"Michael R. Krainock","orcid":"https://orcid.org/0000-0003-0081-4584","observed_orcids":["https://orcid.org/0000-0003-0081-4584"]},"institutions":[{"id":"https://openalex.org/I4210124610","display_name":"Natera (United States)","ror":"https://ror.org/02anzyy56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124610"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Krainock","raw_affiliation_strings":["Department of Oncology, Natera, Inc., Austin, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Natera, Inc., Austin, Texas","institution_ids":["https://openalex.org/I4210124610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160210916","display_name":"Minetta C. Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124610","display_name":"Natera (United States)","ror":"https://ror.org/02anzyy56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124610"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Minetta C. Liu","raw_affiliation_strings":["Department of Oncology, Natera, Inc., Austin, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Natera, Inc., Austin, Texas","institution_ids":["https://openalex.org/I4210124610"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021075410","display_name":"Abhinand Peddada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Abhinand V. Peddada","raw_affiliation_strings":["William N. Pennington Cancer Institute, Reno, Nevada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William N. Pennington Cancer Institute, Reno, Nevada","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021075410"],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":{"value":2500,"currency":"USD","value_usd":2500},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.87667464,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"1","first_page":"102205","last_page":"102205"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.09600000083446503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9990000128746033},{"id":"https://openalex.org/keywords/molecular-residual-disease","display_name":"molecular residual disease","score":0.8690000176429749},{"id":"https://openalex.org/keywords/signatera","display_name":"Signatera","score":0.7229999899864197},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.5699999928474426},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9240000247955322},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/p16-status","display_name":"p16 status","score":0.7200000286102295},{"id":"https://openalex.org/keywords/early-detection-of-recurrence","display_name":"early detection of recurrence","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9711999893188477},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.708899974822998},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6996999979019165},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5748000144958496},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5271000266075134},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.5253999829292297},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.506600022315979},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.5034000277519226},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.49380001425743103},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4519999921321869},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4390000104904175},{"id":"https://openalex.org/C3018411727","wikidata":"https://www.wikidata.org/wiki/Q3867488","display_name":"Head and neck","level":2,"score":0.4081000089645386},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.36550000309944153},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.3465000092983246},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3434999883174896},{"id":"https://openalex.org/C2781335228","wikidata":"https://www.wikidata.org/wiki/Q19596321","display_name":"Circulating tumor DNA","level":3,"score":0.34200000762939453},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.33660000562667847},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.32339999079704285},{"id":"https://openalex.org/C3019992690","wikidata":"https://www.wikidata.org/wiki/Q92767510","display_name":"Basal cell","level":2,"score":0.3230000138282776},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.295199990272522},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.290800005197525},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2888000011444092},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.28450000286102295},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25859999656677246},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2515000104904175}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.adro.2026.102205","doi":"https://doi.org/10.1016/j.adro.2026.102205","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.adro.2026.102205","pdf_url":"https://www.advancesradonc.org/article/S2452-1094(26)00211-3/pdf","source":{"id":"https://openalex.org/S2765008485","display_name":"Advances in Radiation Oncology","issn_l":"2452-1094","issn":["2452-1094"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Radiation Oncology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:43cb3f417ad9478d918dd6097e4660bf","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/43cb3f417ad9478d918dd6097e4660bf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Advances in Radiation Oncology, Vol 12, Iss 1, Pp 102205- (2027)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.adro.2026.102205","doi":"https://doi.org/10.1016/j.adro.2026.102205","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.adro.2026.102205","pdf_url":"https://www.advancesradonc.org/article/S2452-1094(26)00211-3/pdf","source":{"id":"https://openalex.org/S2765008485","display_name":"Advances in Radiation Oncology","issn_l":"2452-1094","issn":["2452-1094"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Radiation Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224766818.pdf","grobid_xml":"https://content.openalex.org/works/W7224766818.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W2939548416","https://openalex.org/W2944044607","https://openalex.org/W3004553637","https://openalex.org/W3047097799","https://openalex.org/W4210586300","https://openalex.org/W4221074099","https://openalex.org/W4281667034","https://openalex.org/W4372336859","https://openalex.org/W4385577082","https://openalex.org/W4386895472","https://openalex.org/W4390971926","https://openalex.org/W4393376479","https://openalex.org/W4399275091","https://openalex.org/W4402582106","https://openalex.org/W4404595546","https://openalex.org/W4409769293","https://openalex.org/W4410590964","https://openalex.org/W4413100613"],"related_works":["https://openalex.org/W7127388022","https://openalex.org/W4281667034","https://openalex.org/W4404875876","https://openalex.org/W4410805308","https://openalex.org/W7122710661","https://openalex.org/W4414537667","https://openalex.org/W7125389576","https://openalex.org/W4410803961","https://openalex.org/W4409769293","https://openalex.org/W7154593501"],"abstract_inverted_index":{"Purpose":[0],"Despite":[1],"advances":[2],"in":[3,53,96,143],"treatments,":[4],"nearly":[5],"half":[6],"of":[7,67,106,126,208,215,229],"the":[8,97,144,178,240],"patients":[9,54,69,218,255],"with":[10,55,70,153,185,246,256,274],"head":[11],"and":[12,30,50,58,114,165,194,201,269,277],"neck":[13],"squamous":[14],"cell":[15],"carcinoma":[16],"(HNSCC)":[17],"experience":[18],"recurrence.":[19],"Early":[20],"recurrence":[21,216,276],"detection":[22],"is":[23,272],"critical":[24],"for":[25,217],"enabling":[26],"timely":[27],"curative":[28],"interventions":[29],"improving":[31],"survival":[32,156,167,279],"outcomes.":[33,280],"Here,":[34],"we":[35],"evaluated":[36],"circulating":[37],"tumor":[38],"DNA":[39],"(ctDNA)":[40],"testing":[41,78],"post-definitive":[42],"treatment":[43,101,117,129,148,180,238,271],"to":[44,73,259],"detect":[45],"molecular":[46],"residual":[47],"disease":[48,275],"(MRD)":[49],"predict":[51],"outcomes":[52],"HNSCC.":[56],"Methods":[57],"Materials":[59],"This":[60],"retrospective":[61],"study":[62],"included":[63],"a":[64,80,206],"real-world":[65],"cohort":[66],"97":[68],"stage":[71,257],"I":[72,258],"IV":[74,260],"HNSCC":[75],"undergoing":[76],"ctDNA":[77],"using":[79],"personalized,":[81],"tumor-informed":[82],"assay":[83],"(Signatera,":[84],"Natera,":[85],"Inc).":[86],"Longitudinal":[87],"plasma":[88],"samples":[89],"(n":[90],"=":[91,163,172,199],"500)":[92],"were":[93,220],"collected":[94],"pretreatment,":[95],"early":[98,145],"postdefinitive":[99,116,146,179,237],"local":[100,109,128,147,267],"setting":[102,149],"(within":[103],"3":[104],"months":[105],"completing":[107],"definitive":[108,127,266],"treatment,":[110],"before":[111],"adjuvant":[112,120,270],"treatment),":[113],"during":[115,177],"surveillance":[118,181],"(after":[119],"therapy":[121,268],"[if":[122],"given]":[123],"or":[124],"postcompletion":[125],"until":[130],"recurrence).":[131],"Results":[132],"Median":[133],"patient":[134],"follow-up":[135],"was":[136,150,183,222,239],"22":[137],"(2-56)":[138],"months.":[139,211],"ctDNA-based":[140,262],"MRD":[141,175,235,263],"positivity":[142,176,236,264],"significantly":[151,186,244],"associated":[152,184,245,273],"inferior":[154],"progression-free":[155],"(PFS)":[157],"(hazard":[158],"ratio":[159],"[HR],":[160],"6.39;":[161],"P":[162,171,191,198,250],".0002)":[164],"overall":[166],"(OS)":[168],"(HR,":[169,189,196,248],"25.72;":[170],".003).":[173],"Longitudinally,":[174],"window":[182],"shorter":[187],"PFS":[188,247],"38.87;":[190],"<":[192,251],".0001)":[193],"OS":[195],"14.37;":[197],".014)":[200],"preceded":[202],"radiographic":[203],"progression":[204],"by":[205],"median":[207],"4.3":[209],"(0.62-21.91)":[210],"The":[212],"increased":[213],"risk":[214],"who":[219],"MRD-positive":[221],"observed":[223],"across":[224],"all":[225],"pathologic":[226],"stages,":[227],"regardless":[228],"p16":[230],"status.":[231],"In":[232,254],"multivariate":[233],"analysis,":[234],"only":[241],"clinicopathologic":[242],"factor":[243],"38.29;":[249],".001).":[252],"Conclusions":[253],"HNSCC,":[261],"after":[265],"poor":[278]},"counts_by_year":[],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2026-10-31T00:00:00"}